MRCCC Siloam Hospitals Semanggi reaffirmed its commitment to providing international-standard cancer services through The 6th Siloam Oncology Summit 2026 held in Jakarta from May 22–24, 2026 (24/05).

The forum carried the theme “United by Unique” and brought together oncology experts from several countries to discuss the latest developments in multidisciplinary and integrated cancer treatment approaches.

The summit also strengthened international collaboration with global healthcare institutions, including The University of Texas MD Anderson Cancer Center.

International Oncology Experts Gather in Jakarta

Siloam Oncology Summit 2026 became a strategic collaboration platform for global healthcare professionals by presenting more than 100 national and international speakers and attracting over 700 healthcare workers from different professions.

Doctors, nurses, pharmacists, and oncology experts attended the event to strengthen synergy in delivering more integrated cancer services with international standards and patient-centered care in Indonesia.

The summit was officially opened on Saturday by Caroline Riady together with dr. Edy Gunawan and drg. Ani Ruspitawati.

Siloam Highlights Integrated and Personalized Cancer Care

Caroline Riady said the Siloam Oncology Summit reflects the company’s commitment to strengthening the quality of cancer services in Indonesia.

She stated that the quality of cancer treatment is determined not only by technology and facilities, but also by the readiness and competence of healthcare workers.

“Siloam continues to strengthen clinical capabilities through continuous learning, multidisciplinary collaboration, and connections with the global medical community to encourage more advanced cancer service standards in Indonesia and Southeast Asia,” she said.

Precision Oncology Encourages Healthcare Readiness

Dr. Edy Gunawan explained that developments in oncology, including precision oncology, require healthcare workers to understand increasingly personalized therapies based on biomarkers and supported by evolving diagnostic technology.

He said the development of quality cancer services requires continuous learning, technology adoption, and multidisciplinary synergy so cancer treatment in Indonesia can continue to progress.

According to him, modern cancer therapy is now focused not only on improving patient survival rates but also on improving quality of life through more personalized approaches with fewer side effects.

MRCCC Siloam Supports National Cancer Plan

Besides serving as a scientific discussion forum, The 6th Siloam Oncology Summit 2026 also reaffirmed the commitment of MRCCC Siloam Hospitals Semanggi to support the implementation of the National Cancer Plan.

The effort focuses on strengthening healthcare worker capabilities, developing clinical research, and encouraging multidisciplinary collaboration across sectors.

Through this initiative, MRCCC Siloam Semanggi continues to encourage the transformation of oncology services through technological innovation, improved medical competencies, and strategic partnerships to strengthen a more integrated, quality, and patient-centered cancer service ecosystem.

PHOTO: MARKETPLUS.ID

This article was created with AI assistance.

We make every effort to ensure the accuracy of our content, some information may be incorrect or outdated. Please let us know of any corrections at [email protected].